Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reata Pharma (NQ: RETA )

90.92 +0.90 (+1.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 851,682
Open 90.00
Bid (Size) 88.70 (10)
Ask (Size) 91.88 (1)
Prev. Close 90.02
Today's Range 88.01 - 93.16
52wk Range 18.47 - 95.00
Shares Outstanding 36,517,928
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
REATA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Reata Pharmaceuticals, Inc. - RETA
From Kahn Swick & Foti, LLC
Via Business Wire
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace

Performance

YTD
+147.67%
+147.67%
1 Month
-2.41%
-2.41%
3 Month
+139.33%
+139.33%
6 Month
+261.80%
+261.80%
1 Year
+177.53%
+177.53%

More News

Read More
Where Reata Pharmaceuticals Stands With Analysts
Via Benzinga
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
Via The Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
The Stock That Tripled in a Day...And May Not Be Done
Via MarketBeat
Why Reata Pharmaceuticals Stock Skyrocketed This Week
Via The Motley Fool
Reata Pharmaceuticals Announces Participation in the Barclays Global Healthcare Conference
From Reata Pharmaceuticals, Inc.
Via Business Wire
REATA PHARMACEUTICALS INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Reata Pharmaceuticals, Inc. - RETA
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
Via Benzinga
Why Is Reata Pharmaceuticals Stock Trading Higher Today?
Via Benzinga
Nasdaq Down 75 Points; B&G Foods Shares Spike Higher
Via Benzinga
Dow Looking To Rebound After Rocky February
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Edges Higher; ISM Manufacturing PMI Rises In February
Via Benzinga
FDA Grants Approval of Reata Pharmaceuticals’ (NASDAQ: RETA) SKYCLARYS Drug, Making the First and Only Drug for Friedreich’s Ataxia
Via Spotlight Growth
Exposures Product Safety
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
US Stocks Edge Lower; Dollar Tree Profit Beats Views
Via Benzinga
Reata Pharmaceuticals Gets Price Target Bumps By Analysts Following FDA Approval Of Skyclarys
Via Benzinga
Investors Just Hit the Jackpot on These 2 Nasdaq Biotech Stocks
Via The Motley Fool
Why Is Novavax (NVAX) Stock Down 26% Today?
Via InvestorPlace
Why Is OKYO Pharma (OKYO) Stock Down 31% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.